The varied outcomes of schizophrenia

Canadian Journal of Psychiatry

Volumn 42, Issue 1, 1997, Pages 34-43

  Davidson, Larry ^a,b   McGlashan, Thomas H ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale University School of Medicine   (United States)

^c Yale New Haven Psychiatric Hospital   (United States)

Author keywords

duration of untreated psychosis; follow up studies; heterogeneity; negative symptoms; onset; outcome; prodrome

Indexed keywords

AFFECT; DEPRESSION; FOLLOW UP; HUMAN; MEDICAL LITERATURE; NEGATIVE SYNDROME; ONSET AGE; REVIEW; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0030980659     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674379704200105     Document Type: Review

References (118)

1. Carpenter WT, Kirkpatrick B. The heterogeneity of the long-term course of schizophrenia. Schizophr Bull 1988;14:645-52.
2. Basic Behavioral Science Task Force of the National Advisory Mental Health Council. Basic behavioral science research for mental health: sociocultural and environmental processes. Am Psychol 1996;51:722-31.
3. Lin KM, Kleinman AM. Psychopathology and clinical course of schizophrenia: a cross-cultural perspective. Schizophr Bull 1988;14:555-67.
4. Harding CM, Brooks GW, Ashikaga T, Strauss JS, Landerl PD. Aging and social functioning in once-chronic schizophrenic patients 22-62 years after first admission: the Vermont story. In: Miller NE, Cohen GD, editors. Schizophrenia, paranoia and schizophreniform disorders in later life. New York: Guilford Press; 1987. p 74-83.
5. Strauss JS, Carpenter WT. Prediction of outcome in schizophrenia, II: relationships between predictor and outcome variables. Arch Gen Psychiatry 1974; 31:37-42.
6. Strauss JS, Carpenter WT. Prediction of outcome in schizophrenia, III: five-year outcome and its predictors: a report from the International Pilot Study of Schizophrenia. Arch Gen Psychiatry 1977;34:159-63.
7. McGlashan TH, Carpenter WT. Long-term follow-up studies of schizophrenia: editors' introduction. Schizophr Bull 1988;14:497-500.
8. Angst J. European long-term follow-up studies of schizophrenia. Schizophr Bull 1988;14:501-13.
9. McGlashan TH. A selective review of recent North American long-term follow-up studies of schizophrenia. Schizophr Bull 1988;14:515-42.
10. Ciompi L. Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophr Bull 1980;6:606-18.
11. Harding CM. Course types in schizophrenia: an analysis of European and American studies. Schizophr Bull 1988;14:633-43.
12. Turner WM, Tsuang MT. Impact of substance abuse on the course and outcome of schizophrenia. Schizophr Bull 1990;16:87-95.
13. Martinez-Arevalo MJ, Calcedo-Ordonez A, Varo-Prieto JR. Cannabis consumption as a prognostic factor in schizophrenia. Br J Psychiatry 1994;164:679-81.
14. Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994;51:273-9.
15. Duke PJ, Pantelis C, Barnes TRE. South Westminster Schizophrenia Survey: alcohol use and its relationship to symptoms, tardive dyskinesia, and illness onset. Br J Psychiatry 1994;164:630-6.
16. DeQuardo JR, Carpenter CF, Tandon R. Patterns of substance abuse in schizophrenia: nature and significance. J Psychiatr Res 1994;28:267-75.
17. Kozaric-Kovacic D, Folnegovic-Smalc V, Folnegovic Z, Marusic A. Influence of alcoholism on the prognosis of schizophrenic patients. J Stud Alcohol 1995; 56:622-7.
18. Chouljian TL, Shumway M, Balancio E, Dwyer EV, Surber R, Jacobs M. Substance use among schizophrenic outpatients: prevalence, course, and relation to functional status. Ann Clin Psychiatry 1995;7:19-24.
19. Smith J, Hucker S. Schizophrenia and substance abuse. Br J Psychiatry 1994; 165:13-21.
20. Drake RE, Wallach MA. Substance abuse among the chronically mentally ill. Hospital and Community Psychiatry 1989;40:1041-6.
21. Test MA, Wallisch LS, Allness DJ, Ripp R. Substance use in young adults with schizophrenic disorders. Schizophr Bull 1989;15:465-76.
22. Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Kee K, and others. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull 1990;16:31-56.
23. Dixon L, Haas G, Weiden PJ, Sweeney J, Frances A. Drug abuse in schizophrenic patients: clinical correlations and reasons for use. Am J Psychiatry 1991; 148:224-30.
24. Zisook S, Heaton R, Moranville J, Kuck J, Jemigan T, Braff D. Past substance abuse and clinical course of schizophrenia Am J Psychiatry 1992;149:552-3.
25. Angermeyer MC, Kuhn L, Goldstein JM. Gender and the course of schizophrenia: differences in treated outcomes. Schizophr Bull 1990;16:293-307.
26. Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A, Geisler S, and others. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am J Psychiatry 1995; 152:698-703.
27. Bardenstein KK, McGlashan TH. Gender differences in affective, schizoaffective, and schizophrenic disorders: a review. Schizophr Res 1990;3:159-72.
28. McGlashan TH, Bardenstein KK. Gender differences in affective, schizoaffective, and schizophrenic disorders. Schizophr Bull 1990;16:319-29.
29. Childers SE, Harding CM. Gender, premorbid social functioning, and long-term outcome in DSM-III schizophrenia. Schizophr Bull 1990;16:309-18.
30. Kendler KS, Walsh D. Gender and schizophrenia: results of an epidemiologically-based family study. Br J Psychiatry 1995;167:184-92.
31. Ohaeri JU. Long-term outcome of treated schizophrenia in a Nigerian cohort: retrospective analysis of 7-year follow-ups. J Nerv Ment Dis 1993;181:514-6.
32. Carpenter WT, Strauss JS. The prediction of outcome in schizophrenia, IV: eleven-year follow-up of the Washington IPSS cohort. J Nerv Ment Dis 1991; 179:517-25.
33. Mason P, Harrison G, Glazebrook C, Medley I, Dalkin T, Croudace T. Characteristics of outcome in schizophrenia at 13 years. Br J Psychiatry 1995; 167:596-603.
34. Shepard M, Watt D, Falloon I, Smeeton N. The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics. Cambridge: Cambridge University Press; 1989.
35. Carone BJ, Harrow M, Westermeyer JF. Posthospital course and outcome in schizophrenia. Arch Gen Psychiatry 1991;48:247-53.
36. Breier A, Schreiber JL, Dyer J, Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Arch Gen Psychiatry 1991;48:239-46.
37. DeSisto MJ, Harding CM, McCormick RV, Ashikaga T, Brooks GW. The Maine and Vermont three-decade studies of serious mental illness, I: matched comparison of cross-sectional outcome. Br J Psychiatry 1995;167:331-38.
38. DeSisto MJ, Harding CM, McCormick RV, Ashikaga T, Brooks GW. The Maine and Vermont three-decade studies of serious mental illness, II: longitudinal course comparisons. Br J Psychiatry 1995;167:338-42.
39. Johnstone EC, Frith CD, Crow TJ, Owens DGC, Done DJ, Baldwin EJ, and others. The Northwick Park 'Functional' Psychosis Study: diagnosis and outcome. Psychol Med 1992;22:331-46.
40. Marneros A, Deister A, Rohde A, Steinmeyer EM, Junemann H. Long-term outcome of schizoaffective and schizophrenic disorders, a comparative study, I: definite methods, psychopathological and social outcome. European Archives of Psyc and Neurological Sciences 1989;238:118-25.
41. Steinmeyer EM, Marneros A, Deister A, Rohde A, Junemann H. Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study, II: causal-analytical investigations. European Archives of Psychiatry and Neurological Sciences 1989;238:126-34.
42. Marneros A, Deister A, Rohde A. Psychopathological and social status of patients with affective, schizophrenic, and schizoaffective disorders after long-term course. Acta Psychiatr Scand 1990;82:352-8.
43. Helgason L. Twenty years' follow-up of first psychiatric presentation for schizophrenia: what could have been prevented? Acta Psychiatr Scand 1990;81:231-5.
44. Geddes JR, Kendell RE. Schizophrenic subjects with no history of admission to hospital. Psychol Med 1995;25:859-68.
45. Harding CM, Brooks GW, Ashikaga T, Strauss JS, Breier A. The Vermont longitudinal study of persons with mental illness, I: methodology, study sample, and overall status 32 years later. Am J Psychiatry 1987;144:718-26.
46. Harding CM, Brooks GW, Ashikaga T, Strauss JS, Breier A. The Vermont longitudinal study of persons with mental illness, II: long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry 1987;144:727-35.
47. Davidson L, McGlashan TH. Schizophrenia: diagnosis and phenomenology. Current Opinion in Psychiatry 1995;8:21-4.
48. Kirch DG, Keith SJ, Matthews SM. Research on first-episode psychosis: report on a National Institute of Mental Health workshop. Schizophr Bull 1992; 18:179-83.
49. Lieberman JA, Matthews SM, Kirch DG. First-episode psychosis, part II: editors' introduction. Schizophr Bull 1992;18:349-50.
50. McGlashan TH. Early detection and intervention in schizophrenia: editor's introduction. Schizophr Bull 1996;22:197-9.
51. Ram R, Bromet EJ, Eaton WW, Pato C, Schwartz JE. The natural course of schizophrenia: a review of first-admission studies. Schizophr Bull 1992; 18:185-207.
52. Eaton WW, Mortensen PB, Herrman H, Freeman H, Bilker W, Burgess P, and others. Long-term course of hospitalization for schizophrenia, part I: risk for hospitalization. Schizophr Bull 1992;18:217-28.
53. Eaton WW, Bilker W, Haro JM, Herrman H, Mortensen PB, Freeman H, and others. Long-term course of hospitalization for schizophrenia, part II: change with passage of time. Schizophr Bull 1992;18:229-11.
54. Lieberman JA, Alvir JMJ, Woerner M, Degreef G, Bilder RM, Ashtari M, and others. Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital. Schizophr Bull 1992;18:351-71.
55. Bilder RM, Lipschultz-Broch L, Reiter G, Geisler SH, Mayerhoff DI, Lieberman JA. Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophr Bull 1992;18:437-48.
56. Nuechterlein KH, Dawson ME, Gitlin M, Ventura J, Goldstein MJ, Snyder KS, and others. Developmental processes in schizophrenic disorders: longitudinal studies of vulnerability and stress. Schizophr Bull 1992;18:387-425.
57. Shtasel DL, Gur RE, Gallacher F, Heiniberg C, Cannon T, Gur RC. Phenomenology and functioning in first-episode schizophrenia. Schizophr Bull 1992; 18:449-62.
58. Szymanski SR, Cannon TD, Gallacher F, Erwin RJ, Gur RE. Course of treatment response in first-episode and chronic schizophrenia. Am J Psychiatry 1996; 153:519-25.
59. Haas GL, Sweeney JA. Premorbid and onset features of first-episode schizophrenia. Schizophr Bull 1992;18:373-86.
60. Larsen TK, McGlashan TH, Moe LC. First-episode schizophrenia, I: early course parameters. Schizophr Bull 1996;22:241-56.
61. Larsen TK, McGlashan TH, Johannessen JO, Vibe-Hansen L. First-episode schizophrenia, II: premorbid patterns by gender. Schizophr Bull 1996;22:257-69.
62. Loebel AD, Lieberman JA, Alvir JMJ, Mayerhoff DI, Geisler SH, Szymanski SR. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992;149:1183-8.
63. McGlashan TH, Johannessen JO. Early detection and intervention with schizophrenia: rationale. Schizophr Bull 1996;22:201-22.
64. Falloon IRH. Early intervention for first episodes of schizophrenia: a preliminary exploration. Psychiatry 1992;55:4-15.
65. Falloon IRH, Kydd RR, Coverdale JH, Laidlaw TM. Early detection and intervention for initial episodes of schizophrenia. Schizophr Bull 1996;22:271-82.
66. Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull 1996;22:283-303.
67. McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 1996;22:305-26.
68. Leff J, Satorius N, Jablensky A, Korten A, Ernberg G. The International Pilot Study of Schizophrenia: five-year follow-up findings. Psychol Med 1992; 22:131-45.
69. Leon CA. Clinical course and outcome of schizophrenia in Cali, Columbia: a 10-year follovv-up study. J Nerv Ment Dis 1989;177:593-606.
70. Verghese A, John JK, Rajkumar S, Richard J, Sethi BB, Trivedi JK. Factors associated with the course and outcome of schizophrenia in India: results of a two-year multicentre follow-up study. Br J Psychiatry 1989;154:499-503.
71. Thara R, Henrietta M, Joseph A, Rajkumar S, Eaton WW. Ten-year course of schizophrenia: the Madras longitudinal study. Acta Psychiatr Scand 1994; 90:329-36.
72. Harrison G, Mason P. Schizophrenia: failing incidence and better outcome? Br J Psychiatry 1993;163:535-41.
73. Der G, Gupta S, Murray R. Is schizophrenia disappearing? Lancet 1990; 335:513-6.
74. Harrison G, Cooper JE, Gancaryczvk R. Changes in the administrative incidence of schizophrenia. Br J Psychiatry 1991;159:811-6.
75. Kendell RE, Malcolm DE, Adams W. The problem of detecting changes in the incidence of schizophrenia. Br J Psychiatry 1993;162:212-8.
76. Abrahamson D. Instilutionalization and the long-term course of schizophrenia. Br J Psychiatry 1993;162:533-8.
77. Wyatt RJ. Neuroleptics and the natural course of schizophrenia. Schizophr Bull 1991;17:325-51.
78. Hegarty JD, Baldessarini RJ, Tohen M, Watemaux C, Oepen G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry 1994;151:1409-16.
79. Strauss JS, Carpenter WT Jr, Bartko JJ. The diagnosis and understanding of schizophrenia part III: speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull 1974;11:61-79.
80. Carpenter WT Jr. The deficit syndrome. Am J Psychiatry 1994;151:327-9.
81. Carpenter WT Jr, Heinrichs DW, Wagman AMI. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 1988;145:578-83.
82. Andreasen NC, Carpenter WT Jr. Diagnosis and classification of schizophrenia. Schizophr Bull 1993;19:199-214.
83. Kane JM, Dauphinais D, Barnes TRE, Adler LA, Rifkin A. Assessing negative symptoms and extrapyramidal symptoms in schizophrenia: workshop report. Psychopharmacol Bull 1993;29:45-9.
84. Tsuang MT. Genotypes, phenotypes, and the brain: a search for connections in schizophrenia. Br J Psychiatry 1993;163:299-307.
85. Kibel DA, Laffont I, Liddle PF. The composition of the negative syndrome of chronic schizophrenia. Br J Psvchiatry 1993;162:744-50.
86. Dollfus S, Petit M, Menard JF. Relationship between depressive and positive symptoms in schizophrenia. J Affect Disord 1993;28:61-9.
87. McGlashan TH, Fenton WS. The positive-negative distinction in schizophrenia: review of natural history validators. In: Widiger TA, Frances AJ, Pincus HA, First MB, Ross R, Davis W, editors. Volume 1, DSM-IV sourcebook. Washington (DC): American Psychiatric Association; 1994. p 381-92.
88. Mameros A, Rohde A, Deister A. Validity of the negative/positive dichotomy of schizophrenic disorders under long-term conditions. Psychopathology 1995; 28:32-7.
89. Eaton WE, Thara R, Federman B, Melton B, Liang K. Structure and course of positive and negative symptoms in schizophrenia. Arch Gen Psychiatry 1995; 52:127-34.
90. Van der Does AJW, Dingemans PM, Lnszen DH, Nugter MA, Scholte WF. Symptom dimensions and cognitive and social functioning in recent-onset schizophrenia. Psychol Med 1993;23:745-53.
91. Hwu HG, Tan H, Chen CC, Yeh LL. Negative symptoms at discharge and outcome in schizophrenia. Br J Psychiatry 1995;166:61-7.
92. Fenton WS, McGlashan TH. Antecedents, svmptom progression, and long-term outcome of the deficit syndrome in schizophrenia. Am J Psychiatry 1994; 151:351-6.
93. Arndt S, Andreasen NC, Flaum M, Miller D, Nopoulos P. A longitudinal study of symptom dimensions in schizophrenia. Arch Gen Psychiatry 1995;52:352-60.
94. Liddle PF. The symptoms of chronic schizophrenia: A re-examination of the positive-negative dichotomy. Br J Psychiatry 1987;151:145-51.
95. Malla AK, Norman RMG, Williamson P, Cortese L, Diaz F. Three syndrome concept of schizophrenia: a factor analytic study. Schizophr Res 1993;10:143-50.
96. Miller DD, Arndt S, Andreasen NC. Alogia, attentional impairment, and inappropriate affect: their status in the dimensions of schizophrenia. Compr Psychiatry 1993;34:221-6.
97. Lenzenweger MF, Dworkin RH, Wethington E. Examining the underlying structure of schizophrenic phenomenology: evidence for a three-process model. Schizophr Bull 1991;17:515-24.
98. Van der Does AJW, Linszen DH, Dingemans PM, Nugler MA, Scholte WF. A dimensional and categorical approach to the symptomatology of recent-onset schizophrenia. J Nerv Ment Dis 1993;181:744-9.
99. Van der Does AJW, Dingemans PMAJ, Linszen DH, Nugter MA, Scholte WF. Dimensions and subtypes of recent-onset schizophrenia: a longitudinal analysis. J Nerv Ment Dis 1995;183:681-7.
100. Goldberg TE, Hyde TM, Kleinman JE, Weinberger DR. Course of schizophrenia: neuropsychological evidence for a static encephalopathy. Schizophr Bull 1993; 19:797-804
101. Harvey PD, White L, Parrella M, Putnam KM, Kincaid MM, Powchik P, and others. The longitudinal stability of cognitive impairment in schizophrenia: mini mental state scores at one-and two-year follow-ups in geriatric inpatients. Br J Psychiatry 1995;166:630-3.
102. Harvey PD, Lombardi J, Kincaid MM, Parrella M, White L, Powchik P, and others. Cognitive functioning in chronically hospitalized schizophrenic patients: age-related changes and age disorientation as a predictor of impairment. Schizophr Res 1995;17:15-24.
103. Lysaker PH, Bell M, Bioty SM. Cognitive deficits in schizophrenia: prediction of symptom change for participators in work rehabilitation. J Nerv Ment Dis 1995; 183:332-6.
104. Lysaker PH, Bell MD, Zito WS, Bioty SM. Social skills at work: deficits and predictors of improvement in schizophrenia. J Nerv Ment Dis 1995;183:688-92.
105. Green MF, Satz P, Ganzell S, Vaclav FJ. Wisconsin Card Sorting Test performance in schizophrenia: remediation of a stubborn deficit. Am J Psychiatry 1992; 149:62-7.
106. Spring BJ, Ravin L. Cognitive remediation in schizophrenia: should we attempt it? Schizophr Bull 1992;18:15-20.
107. Liberman RP, Green MF. Wither cognitive behavioral therapy for schizophrenia? Schizophr Bull 1992;18:27-35.
108. Jaeger J, Douglas E. Neuropsychiatric rehabilitation for persistent mental illness. Psychiatr Q 1992;63:71-94.
109. Green MF. Cognitive remediation in schizophrenia: is it time yet? Am J Psychiatry 1993;150:178-87.
110. Benedict RH, Harris A. Remediation of attention deficits in chronic schizophrenic patients: a preliminary study. Br J Clin Psychol 1989;28:187-8.
111. Delahunty A, Morice R, Frost B. Specific cognitive flexibility rehabilitation in schizophrenia. Psychol Med 1993;23:221-7.
112. Bellack AS. Cognitive rehabilitation for schizophrenia: is it possible? is it necessary? Schizophr Bull 1992;18:43-50.
113. McGlashan TH, Carpenter WT Jr, Bartko JJ. Issues of design and methodology in long-term follow-up studies. Schizophr Bull 1988;14:569-74.
114. Keshavan MS, Schooler NR. First-episode studies in schizophrenia: criteria and characterization. Schizophr Bull 1992;18:491-513.
115. Flaum MA, Andreasen NC, Arndt S. The Iowa prospective longitudinal study of recent-onset psychoses. Schizophr Bull 1992;18:481-90.
116. McGlashan TH. Early detection and intervention in schizophrenia: research. Schizophr Bull 1996;22:327-45.
117. Sullivan P. Recovery from schizophrenia: what we can learn from the developing nations. Innovations & Research 1994;3:7-15.
118. Rund BR. Fully recovered schizophrenics: a retrospective study of some premorbid and treatment factors. Psychiatry 1990;53:127-39.